Chrisy Ngilneii's Profile
B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)
Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on Amazon.in. When she is not writing or editing, you will see her playing guitar or piano.
Written / Edited / Medically Reviewed
Novel genomics tool enables more accurate identification of rare mutations in cancer cells. This new computational method allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
A novel signaling pathway for brain metastases in triple negative breast cancer has been identified. This may help find a promising strategy for metastatic breast cancer prevention and treatment by targeting organ-adaptive cancer stem cells.
Ribosomes, which create proteins in every cell of the body, have been linked to blood stem cell differentiation. This finding could lead to a potential new therapeutic pathway to treat Diamond-Blackfan anemia, a severe, rare, congenital blood disorder.
Nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study could open the door to new targeted therapies for this debilitating disease in the future.
The compound semaglutide that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight. Semaglutide can be used in addition to diet and exercise to improve glycemic control in adults with type-2 diabetes.